PEMED 2018

25/06/2018 - 27/06/2018 Paris

PEMED 2018 is the first edition of an international conference on Personalized and Precision Medicine. It’s a very good opportunity to share your research and meet the best experts in the field.

Whether you are interested in diagnostics, bioinformatics, drug discovery, and therapies, with the aim of translating precision medicine into direct improvements in health care, PEMED 2018 is the place to be, to meet, discuss and eventually do business in this exciting new space.

 

PEMED 2018 June 25-27

PEMED 2018 will be held in the heart of Paris, at Asiem

Submission by April 16

Registration by May 16

pemed2018@premc.org

www.premc.org/pemed

 

TOPICS

  • Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, etc.)
  • Biomarkers and diagnostics, liquid biopsy, imaging, biochip/microarray technologies, advancements in technologies
  • Drug target discovery and integration with individualized therapy, integration of diagnosis with therapy(theragnosis)
  • Integrating Big Data (genome data, pharmacogenomics, therapeutic applications of genome editing, genetic analysis in clinical trials methodology, etc.)
  • Emerging opportunities in personalized medicine, cutting-edge new strategies and solutions
  • Cost-benefit issues, and ethics in precision medicine

PLENARY SPEAKERS

  • Prof. Jacques Beckmann – University of Lausanne, Switzerland
  • Prof. Anna Dominiczak – University of Glasgow, UK
  • Prof. Klaus Pantel – Center for Experimental Medicine, Germany
  • Prof. Anne-Marie Caminade – Coordination Chemistry Lab of Toulouse and University of Toulouse, France
  • Prof. Fabrice André – Gustave Roussy Institute, France
  • Prof. Yosef Yarden – Weizmann Institute of Science, Israel
  • Prof. Richard Weinshilboum – Mayo Clinic, USA
  • Prof. Matthias Schwab – IKP Stuttgart and University Hospital Tuebingen, Germany
  • Prof. Xiangyang Shi – Donghua University, China
  • Prof. Søren Brunak – Technical University of Denmark
  • Prof. Manuel Perucho – Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Spain
  • Dr. Philip Murphy – National Institute of Allergy and Infectious Diseases, USA